UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

If you want to go far, go together: standardisation and data sharing in TB drug development

The international journal of tuberculosis and lung disease, 2024-01, Vol.28 (1), p.3-5

2024

Volltextzugriff (PDF)

Pharmacokinetics of rifampicin in adult TB patients and healthy volunteers: a systematic review and meta-analysis

Journal of antimicrobial chemotherapy, 2018-09, Vol.73 (9), p.2305-2313

2018

Volltextzugriff (PDF)

Clinical relevance of non-tuberculous mycobacteria isolated in the Nijmegen-Arnhem region, The Netherlands

Thorax, 2009-06, Vol.64 (6), p.502-506

2009

Volltextzugriff (PDF)

Low-level rifampicin-resistant Mycobacterium tuberculosis strains raise a new therapeutic challenge

The international journal of tuberculosis and lung disease, 2011-07, Vol.15 (7), p.990-992

2011

Volltextzugriff (PDF)

Pharmacokinetics, Tolerability, and Bacteriological Response of Rifampin Administered at 600, 900, and 1,200 Milligrams Daily in Patients with Pulmonary Tuberculosis

Antimicrobial agents and chemotherapy, 2017-11, Vol.61 (11)

2017

Volltextzugriff (PDF)

UNITE4TB: a new consortium for clinical drug and regimen development for TB

The international journal of tuberculosis and lung disease, 2021-11, Vol.25 (11), p.886-889

2021

Volltextzugriff (PDF)

Environmental sources of rapid growing nontuberculous mycobacteria causing disease in humans

Clinical microbiology and infection, 2009-10, Vol.15 (10), p.888-893

2009

Volltextzugriff (PDF)

The changing pattern of clinical Mycobacterium avium isolation in the Netherlands

The international journal of tuberculosis and lung disease, 2010-09, Vol.14 (9), p.1176

2010

Volltextzugriff (PDF)

Pharmacokinetics of Adjusted-Dose Lopinavir-Ritonavir Combined with Rifampin in Healthy Volunteers

Antimicrobial Agents and Chemotherapy, 2004-05, Vol.48 (5), p.1553-1560

2004

Volltextzugriff (PDF)

Population pharmacokinetics and limited sampling strategy for first-line tuberculosis drugs and moxifloxacin

International journal of antimicrobial agents, 2014-09, Vol.44 (3), p.229-234

2014

Volltextzugriff (PDF)

Mycobacterium genavense in the Netherlands: an opportunistic pathogen in HIV and non-HIV immunocompromised patients. An observational study in 14 cases

Clinical microbiology and infection, 2013-05, Vol.19 (5), p.432-437

2013

Volltextzugriff (PDF)

Proposal to elevate Mycobacterium avium complex ITS sequevar MAC-Q to Mycobacterium vulneris sp. nov

International journal of systematic and evolutionary microbiology, 2009-09, Vol.59 (9), p.2277-2282

2009

Volltextzugriff (PDF)

Diagnosis, treatment and transmission of rifampicin-resistant TB in the Netherlands, 2010-2019

The international journal of tuberculosis and lung disease, 2023-06, Vol.27 (6), p.471-477

2023

Volltextzugriff (PDF)

Clinical relevance of Mycobacterium malmoense isolation in the Netherlands

The European respiratory journal, 2009-10, Vol.34 (4), p.926-931

2009

Volltextzugriff (PDF)

Highly successful treatment outcome of multidrug-resistant tuberculosis in the Netherlands, 2000-2009

The international journal of tuberculosis and lung disease, 2015-04, Vol.19 (4), p.406-412

2015

Volltextzugriff (PDF)

Rapid diagnosis of pyrazinamide-resistant multidrug-resistant tuberculosis using a molecular-based diagnostic algorithm

Clinical microbiology and infection, 2014-10, Vol.20 (10), p.1015-1020

2014

Volltextzugriff (PDF)

Clinical relevance of Mycobacterium simiae in pulmonary samples

The European respiratory journal, 2008-01, Vol.31 (1), p.106-109

2008

Volltextzugriff (PDF)

Xpert MTB/RIF®, a novel automated polymerase chain reaction-based tool for the diagnosis of tuberculosis

The international journal of tuberculosis and lung disease, 2011-07, Vol.15 (7), p.988-989

2011

Volltextzugriff (PDF)

The rising incidence and clinical relevance of Mycobacterium malmoense: a review of the literature

The international journal of tuberculosis and lung disease, 2008-09, Vol.12 (9), p.987

2008

Volltextzugriff (PDF)

Breakpoints and drug exposure are inevitably closely linked

Antimicrobial agents and chemotherapy, 2015-02, Vol.59 (2), p.1384-1384

2015

Volltextzugriff (PDF)

Pharmacokinetic studies in patients with nontuberculous mycobacterial lung infections

International journal of antimicrobial agents, 2013-09, Vol.42 (3), p.256-261

2013

Volltextzugriff (PDF)

Serum 25-hydroxy-vitamin D3 concentrations increase during tuberculosis treatment in Tanzania

The international journal of tuberculosis and lung disease, 2010-09, Vol.14 (9), p.1147

2010

Volltextzugriff (PDF)

Ebola, fragile health systems and tuberculosis care: a call for pre-emptive action and operational research

The international journal of tuberculosis and lung disease, 2015-11, Vol.19 (11), p.1271-1275

2015

Volltextzugriff (PDF)

Re-analysis of 178 previously unidentifiable Mycobacterium isolates in the Netherlands in 1999–2007

Clinical microbiology and infection, 2010-09, Vol.16 (9), p.1470-1474

2010

Volltextzugriff (PDF)

1 – 25 von 197

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(180)
Mit Volltextzugriff
(155)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(157)
Life Sciences & Biomedicine
(152)
Humans
(119)
Infectious Diseases
(85)
Female
(77)
Male
(74)
Biological And Medical Sciences
(65)
Adult
(64)
Medical Sciences
(57)
Tuberculosis
(51)
Middle Aged
(45)
Respiratory System
(44)
Microbiology
(43)
Bacterial Diseases
(38)
Human Bacterial Diseases
(38)
Tuberculosis And Atypical Mycobacterial Infections
(35)
Adolescent
(28)
Antitubercular Agents - Therapeutic Use
(28)
Aged
(26)
Mycobacterium Tuberculosis
(25)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

If you want to go far, go together: standardisation and data sharing in TB drug development

Pharmacokinetics of rifampicin in adult TB patients and healthy volunteers: a systematic review and meta-analysis

Clinical relevance of non-tuberculous mycobacteria isolated in the Nijmegen-Arnhem region, The Netherlands

Low-level rifampicin-resistant Mycobacterium tuberculosis strains raise a new therapeutic challenge

Pharmacokinetics, Tolerability, and Bacteriological Response of Rifampin Administered at 600, 900, and 1,200 Milligrams Daily in Patients with Pulmonary Tuberculosis

UNITE4TB: a new consortium for clinical drug and regimen development for TB

Environmental sources of rapid growing nontuberculous mycobacteria causing disease in humans

The changing pattern of clinical Mycobacterium avium isolation in the Netherlands

Pharmacokinetics of Adjusted-Dose Lopinavir-Ritonavir Combined with Rifampin in Healthy Volunteers

Population pharmacokinetics and limited sampling strategy for first-line tuberculosis drugs and moxifloxacin

Mycobacterium genavense in the Netherlands: an opportunistic pathogen in HIV and non-HIV immunocompromised patients. An observational study in 14 cases

Proposal to elevate Mycobacterium avium complex ITS sequevar MAC-Q to Mycobacterium vulneris sp. nov

Diagnosis, treatment and transmission of rifampicin-resistant TB in the Netherlands, 2010-2019

Clinical relevance of Mycobacterium malmoense isolation in the Netherlands

Highly successful treatment outcome of multidrug-resistant tuberculosis in the Netherlands, 2000-2009

Rapid diagnosis of pyrazinamide-resistant multidrug-resistant tuberculosis using a molecular-based diagnostic algorithm

Clinical relevance of Mycobacterium simiae in pulmonary samples

Xpert MTB/RIF®, a novel automated polymerase chain reaction-based tool for the diagnosis of tuberculosis

The rising incidence and clinical relevance of Mycobacterium malmoense: a review of the literature

Breakpoints and drug exposure are inevitably closely linked

Pharmacokinetic studies in patients with nontuberculous mycobacterial lung infections

Serum 25-hydroxy-vitamin D3 concentrations increase during tuberculosis treatment in Tanzania

Ebola, fragile health systems and tuberculosis care: a call for pre-emptive action and operational research

Re-analysis of 178 previously unidentifiable Mycobacterium isolates in the Netherlands in 1999–2007

Suchergebnisse filtern